CHEDDAR TV describes the medical device market as a $155 Billion opportunity this year, and Ra Medical Systems's President Jeffrey Kraw tells reporters that this 17 year-old company, with more than 1,000 excimer lasers already being used by doctors around the world, is poised to capitalize on it. Kraws explains how its newest product, the DABRA Laser System, which is FDA cleared to treat the toughest blockages in the lower extremities, unclogs arteries. The company's product portfolio was launched in 2004 with Pharos, which treats tough dermatological disorders. Kraws discusses the long journey of bringing a medical device to market, including the FDA clearance process.
He says the most complicated part is always,
"...demonstrating the safety in every known possible situation you can in order to satisfy the FDA that the product is safe for all patients' use."
Ra Medical Systems' FDA study results demonstrated a 95% success rate with no adverse events.
Watch the interview on CHEDDAR TV to learn more about how this compares to Ra Medical Systems' leading competitor in the market:
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly